+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Beta-1 Receptors Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
mGlu 2/3 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

mGlu 2/3 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
AMPA Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

AMPA Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
IL-6 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

IL-6 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
P2Y12 Platelet ADP Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

P2Y12 Platelet ADP Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Factor VIIa Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Factor VIIa Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A3 Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glabellar Lines - Pipeline Insight, 2025 - Product Thumbnail Image

Glabellar Lines - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hypercholesterolaemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypercholesterolaemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
mGlu 2/3/5 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

mGlu 2/3/5 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclophilin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclophilin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Selective COX-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Selective COX-2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta Secretase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Secretase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plasminogen Activator Inhibitor-1 (PAI-1) - Pipeline Insight, 2025 - Product Thumbnail Image

Plasminogen Activator Inhibitor-1 (PAI-1) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more